Zhang Guanyu, Li Yiran, Xu Jiasheng, Xiong Zhenfang
Queen Mary college of Nanchang University, Xuefu Road, Nanchang, Jiangxi 330001, China.
Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Open Med (Wars). 2020 Oct 12;15(1):1003-1011. doi: 10.1515/med-2020-0205. eCollection 2020.
Osteosarcoma (OS) is the most common primary malignant tumor of the skeletal system in the clinic. It mainly occurs in adolescent patients and the pathogenesis of the disease is very complicated. The distant metastasis may occur in the early stage, and the prognosis is poor. MicroRNAs (miRNAs) are non-coding RNAs of about 18-25 nt in length that are involved in post-transcriptional regulation of genes. miRNAs can regulate target gene expression by promoting the degradation of target mRNAs or inhibiting the translation process, thereby the proliferation of OS cells can be inhibited and the apoptosis can be promoted; in this way, miRNAs can affect the metabolism of OS cells and can also participate in the occurrence, invasion, metastasis, and recurrence of OS. Some miRNAs have already been found to be closely related to the prognosis of patients with OS. Unlike other reviews, this review summarizes the miRNA molecules closely related to the development, diagnosis, prognosis, and treatment of OS in recent years. The expression and influence of miRNA molecule on OS were discussed in detail, and the related research progress was summarized to provide a new research direction for early diagnosis and treatment of OS.
骨肉瘤(OS)是临床上最常见的骨骼系统原发性恶性肿瘤。它主要发生于青少年患者,其发病机制非常复杂。疾病早期可能发生远处转移,预后较差。微小RNA(miRNA)是长度约为18 - 25个核苷酸的非编码RNA,参与基因的转录后调控。miRNA可通过促进靶mRNA的降解或抑制翻译过程来调控靶基因表达,从而抑制OS细胞的增殖并促进其凋亡;通过这种方式,miRNA可影响OS细胞的代谢,还可参与OS的发生、侵袭、转移及复发。一些miRNA已被发现与OS患者的预后密切相关。与其他综述不同,本综述总结了近年来与OS的发生发展、诊断、预后及治疗密切相关的miRNA分子。详细讨论了miRNA分子对OS的表达及影响,并总结了相关研究进展,为OS的早期诊断和治疗提供新的研究方向。